Atria Wealth Solutions Inc. Buys Shares of 7,418 Xylem Inc. (NYSE:XYL)

Key Points

• Atria Wealth Solutions Inc. purchased 7,418 shares of Xylem Inc. valued at approximately $886,000, marking a new investment position in the company.
• Analysts have raised their price targets for Xylem, with UBS Group setting a new target of $168.00 and Citigroup increasing theirs to $152.00, while maintaining a "buy" rating.
• Xylem reported a quarterly earnings per share (EPS) of $1.26, exceeding consensus estimates, alongside a 6.1% year-over-year revenue increase.

Atria Wealth Solutions Inc. acquired a new stake in shares of Xylem Inc. (NYSE:XYL - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,418 shares of the industrial products company's stock, valued at approximately $886,000.

Other hedge funds have also recently bought and sold shares of the company. Northern Trust Corp grew its position in shares of Xylem by 42.0% in the 4th quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock worth $379,204,000 after acquiring an additional 966,399 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd grew its position in shares of Xylem by 390.5% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock worth $122,009,000 after acquiring an additional 813,100 shares in the last quarter. Vaughan Nelson Investment Management L.P. acquired a new position in shares of Xylem in the 1st quarter worth approximately $89,828,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Xylem in the 4th quarter worth approximately $83,139,000. Finally, GAMMA Investing LLC grew its position in shares of Xylem by 15,322.5% in the 1st quarter. GAMMA Investing LLC now owns 506,630 shares of the industrial products company's stock worth $60,522,000 after acquiring an additional 503,345 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Stock Performance

Shares of NYSE XYL traded down $1.66 during mid-day trading on Thursday, hitting $141.87. The company had a trading volume of 779,094 shares, compared to its average volume of 1,483,138. The stock has a market cap of $34.53 billion, a price-to-earnings ratio of 36.85, a PEG ratio of 2.49 and a beta of 1.11. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $145.33. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The firm's 50 day simple moving average is $132.23 and its two-hundred day simple moving average is $125.57.

Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.11. The firm had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%. The firm's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.09 EPS. As a group, equities research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently commented on XYL. UBS Group lifted their target price on Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Raymond James Financial upgraded Xylem to a "hold" rating in a research report on Thursday, May 15th. JPMorgan Chase & Co. started coverage on Xylem in a research report on Friday, May 30th. They issued an "overweight" rating and a $148.00 target price for the company. Robert W. Baird cut their price target on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a report on Wednesday, April 30th. Finally, Citigroup reissued a "buy" rating and issued a $152.00 price target (up previously from $137.00) on shares of Xylem in a report on Monday, July 14th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $151.57.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.